Antibiotic synergy against viridans streptococci isolated in infective endocarditis

Int J Antimicrob Agents. 2015 May;45(5):550-1. doi: 10.1016/j.ijantimicag.2015.01.002. Epub 2015 Feb 2.

Authors

Torgny Sunnerhagen¹, Bo Nilson², Magnus Rasmussen³

Affiliations

¹ Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden.
² Clinical Microbiology, Region Skåne, Lund, Sweden; Division of Medical Microbiology, Department of Laboratory Medicine, Lund University, Lund, Sweden.
³ Division of Infection Medicine, Department of Clinical Sciences, Lund University, Lund, Sweden. Electronic address: magnus.rasmussen@med.lu.se.

PMID: 25697413
DOI: 10.1016/j.ijantimicag.2015.01.002

No abstract available

Publication types

Letter
Research Support, Non-U.S. Gov't

MeSH terms

Anti-Bacterial Agents / pharmacology*
Drug Synergism*
Endocarditis / microbiology*
Humans
Microbial Sensitivity Tests
Microbial Viability / drug effects
Streptococcal Infections / microbiology*
Viridans Streptococci / drug effects*
Viridans Streptococci / physiology

Substances

Anti-Bacterial Agents